Á¦26Â÷ ¾Æ½Ã¾Æ ÅÂÆò¾ç È£Èí±â Çмú´ëȸ (APSR 2022)(3ÀÏÂ÷) : 2022-11-19±³À°ÀÏÀÚ : 2022-11-19
±³À°Àå¼Ò : Coex, Seoul, Korea
±³À°ÁÖÁ¦ :
Á¦26Â÷ ¾Æ½Ã¾Æ ÅÂÆò¾ç È£Èí±â Çмú´ëȸ (APSR 2022)(3ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ
´ã´çÀÚ : ±è¹Ì¼±
¿¬¶ôó : 02-575-3825
À̸ÞÀÏ :
katrd@hanmail.net ±³À°Á¾·ù : ³»°úÀÇÇб³À°, ±âŸ,
Âü¼®¿¹»óÀοø : 3000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 8 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 1,125,000¿ø
ºñ°í Standard(17 Sep – 4 Nov) USD 750 Onsite(17 Nov - 20 Nov) USD 850
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-19 Auditorium 08:10~08:40 Chronic lung diseases: COPD and bronchiectasis Chong-Jen Yu(National Taiwan University College of Medicine, Taiwan)
±³À°½Ã°£ 11-19 Auditorium 08:40~09:10 Why Improve the Management of Chronic Cough in Children Through Clinical Care and Research? Anne Chang(Australia)
±³À°½Ã°£ 11-19 Auditorium 09:20~09:50 Up-To-Date Research of Microbiome in COPD and Clinical Implication Don Sin(University of British Columbia, St. Paul Hospital, Canada)
±³À°½Ã°£ 11-19 Auditorium 09:50~10:20 Who Needs ICS in COPD Richard Russell(University of Oxford, United Kingdom)
±³À°½Ã°£ 11-19 Auditorium 10:20~10:50 BCO (Bronchiectasis COPD Overlap): Severe Phenotype or Simple Comorbidity? Ji Ye Jung(Yonsei University College of Medicine, Republic of Korea)
±³À°½Ã°£ 11-19 Auditorium 11:10~12:40 Successful Strategy in Diagnosis and Management of Difficult-To-Treat/Severe Asthma in Real Clinical Practice Parameswaran Nair(McMaster University, Canada)
±³À°½Ã°£ 11-19 Grand Ballroom 14:00~14:30 Management of CAP in the Era of COVID-19 Girish B. Nair(Oakland University William Beaumont School of Medicine, U.S.A.)
±³À°½Ã°£ 11-19 Grand Ballroom 14:30~15:00 Recent Advances in the Aspiration Pneumonia Chieh-Liang Wu(Taichung Veterans General Hospital, Taiwan)
±³À°½Ã°£ 11-19 Grand Ballroom 15:00~15:30 Advances in the Management of Fungal Pneumonia in Critically Ill Patients Jin-won Huh(University of Ulsan College of Medicine, Republic of Korea)
±³À°½Ã°£ 11-19 Auditorium 15:50~16:20 ILA: Natural Course and Clinical Implication Takeshi Johkoh(Kansan Rosai Hospital, Japan)
±³À°½Ã°£ 11-19 Auditorium 16:20~16:50 Evaluation of ILA by Automatic Quantification System Grace H. Kim(UCLA, U.S.A.)
±³À°½Ã°£ 11-19 Auditorium 16:50~17:20 ILA in Asian Population Gong Yong Jin(Jeonbuk National University, Republic of Korea)
±³À°½Ã°£ 11-19 Grand Ballroom 17:30~18:30 Biological Treatment for Type 2 Severe Asthma: The Role and Contribution of IL-4/IL-13 Nicola Hananiah(Baylor College of Medicine, U.S.A.)